Haystack Analytics-Infexn, an IIT Bombay-incubated company specializing in genomics and big data, has developed a robust drug resistance test for tuberculosis (TB). In an email interview, Chaitali Nikam, the director of the company, emphasizes the critical role of whole-genome sequencing in tackling the treatable TB epidemic in India. The comprehensive test offers insights into drug resistance, facilitating more targeted and effective treatments. Nikam discusses the significance of advanced genomics in the fight against TB, shedding light on the potential impact of technology-driven solutions in eliminating this public health challenge.